CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 86 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,893,300 | -12.8% | 666,661 | 0.0% | 0.56% | -17.4% |
| Q3 2022 | $4,467,000 | +110.2% | 666,661 | +32.1% | 0.68% | +102.7% |
| Q2 2022 | $2,125,000 | -9.2% | 504,661 | +267.8% | 0.34% | +53.0% |
| Q1 2017 | $2,340,000 | +106.7% | 137,212 | +24.7% | 0.22% | -1.4% |
| Q4 2016 | $1,132,000 | +12.0% | 110,000 | +10.0% | 0.22% | +20.0% |
| Q3 2016 | $1,011,000 | -10.0% | 100,000 | 0.0% | 0.18% | -22.9% |
| Q2 2016 | $1,123,000 | -17.8% | 100,000 | 0.0% | 0.24% | -16.4% |
| Q1 2016 | $1,366,000 | – | 100,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |